Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
Clinical trial NCT03004638 · COMPLETED
Trial details
- NCT number
- NCT03004638
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-23
- Primary completion
- 2017-11-02
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.